Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05458843 · ClinicalTrials.gov registry record · NA

Renal Considerations in the Heat Stress Recommendations (Aim2)

A NA study of Dehydration and Hyperthermia, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05458843 is a NA study of Dehydration and Hyperthermia that has completed, run by Indiana University. The registered enrollment target is 18 participants, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05458843, a NA study of Dehydration and Hyperthermia, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is largely unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration that elicit oxidative stress and inflammation in the renal tubules. The purpose of this study is to determine whether hydration status modifies the development of renal oxidative stress and inflammation.

Interventions

  • PROCEDURE Fluid replacement
  • PROCEDURE No fluid replacement

Study Locations (1)

Indiana

  • School of Public Health - Bloomington

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-08-01
Est. Completion 2023-05-22
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05458843

The ClinicalTrials.gov registry entry for NCT05458843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (68% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Dehydration appearing as the primary indexed condition, and to 2 interventions - of which Fluid replacement is the first listed.

NCT05458843 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05458843 about?

NCT05458843 is a clinical study titled "Renal Considerations in the Heat Stress Recommendations (Aim2)". An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is largely unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration that elicit oxidative stress and inflammatio...

What is the current status of trial NCT05458843?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-08-01. Estimated completion is 2023-05-22.

What conditions does trial NCT05458843 study?

This clinical trial studies the following conditions: Dehydration, Hyperthermia, Kidney Injury, Kidney Dysfunction, Hot Weather; Adverse Effect.

What interventions are being tested in trial NCT05458843?

The interventions under investigation include: Fluid replacement (PROCEDURE), No fluid replacement (PROCEDURE).

Who is sponsoring clinical trial NCT05458843?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05458843 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.